Schroder Investment Management Group Has $48.12 Million Holdings in Masimo Corporation $MASI

Schroder Investment Management Group decreased its holdings in Masimo Corporation (NASDAQ:MASI) by 24.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 336,650 shares of the medical equipment provider’s stock after selling 111,851 shares during the quarter. Schroder Investment Management Group owned approximately 0.63% of Masimo worth $48,121,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. MAI Capital Management lifted its position in Masimo by 176.7% during the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock worth $34,000 after buying an additional 129 shares in the last quarter. Smartleaf Asset Management LLC increased its position in Masimo by 80.0% in the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 136 shares in the last quarter. Allworth Financial LP raised its stake in shares of Masimo by 72.8% in the second quarter. Allworth Financial LP now owns 387 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 163 shares during the last quarter. Clearstead Advisors LLC lifted its position in shares of Masimo by 18.4% during the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73 shares in the last quarter. Finally, Hantz Financial Services Inc. lifted its position in shares of Masimo by 792.3% during the third quarter. Hantz Financial Services Inc. now owns 580 shares of the medical equipment provider’s stock worth $86,000 after purchasing an additional 515 shares in the last quarter. Institutional investors own 85.96% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Monday, December 1st. Stifel Nicolaus set a $180.00 price objective on Masimo in a research report on Tuesday, February 17th. Piper Sandler cut Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price for the company. in a research note on Tuesday, February 17th. Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Finally, BTIG Research lowered Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. One analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $181.17.

Masimo Stock Performance

Masimo stock opened at $175.49 on Wednesday. The company’s 50-day moving average price is $149.02 and its 200-day moving average price is $145.23. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72. The company has a market cap of $9.43 billion, a PE ratio of -16.65, a price-to-earnings-growth ratio of 1.78 and a beta of 1.21. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $175.90.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.